Functional Neuromodulation

medical devices

About

Functional Neuromodulation Ltd. is a medical technology start-up based in Minneapolis, Minnesota, established in 2010. The company specializes in developing advanced neuromodulation technologies, particularly deep brain stimulation (DBS) therapies aimed at treating cognitive and memory disorders, including mild Alzheimer's disease. The company is focused on innovating DBS treatments to enhance cognitive function and slow disease progression. A key initiative is the ADvance II study, a clinical trial assessing the safety and efficacy of deep brain stimulation of the fornix in patients with mild probable Alzheimer's disease. This research aims to show that DBS-f stimulation can effectively slow cognitive decline. Functional Neuromodulation's leadership includes CEO Vince Owens and Founding Scientist Dr. Andres Lozano. The company targets healthcare providers, neurologists, and neurosurgeons, offering new therapeutic options for patients with cognitive impairments. Its work contributes to the growing deep brain stimulation devices market, addressing the increasing prevalence of neurological disorders.

Technologies

Nginx Mobile Friendly Apache

Keywords

neuromodulation deep brain stimulation alzheimers disease dbs clinical studies clinical trials clinical research dementia neurology neurosurgery mild alzheimers disease alzheimers research alzheimers trial alzheimers study medical equipment manufacturing health care health wellness & fitness hospital & health care medical devices

Location

Minneapolis, Minnesota, United States, 55415

Related Companies

Companies in the same industry